Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Endometrial Cancer News

News
Cost-Effectiveness Analysis of Immunotherapy Regimes in Upfront Treatment With Chemotherapy for Endometrial Cancer
03/19/2024
Alex Francoeur, MD, and colleagues investigated the cost-effectiveness of immunotherapy regimes in upfront treatment with chemotherapy for patients with endometrial cancer.
Alex Francoeur, MD, and colleagues investigated the cost-effectiveness of immunotherapy regimes in upfront treatment with chemotherapy for patients with endometrial cancer.
Alex Francoeur, MD, and...
03/19/2024
Journal of Clinical Pathways
News
Molecular Classification to Predict Prognosis and Relapse Patterns Among Patients With Low/Intermediate-Risk Endometrial Cancer
02/13/2024

Stephanie Holland 

Stephanie Holland 
Results from a retrospective cohort study found that molecular classification can predict prognosis and relapse patterns among patients with low or intermediate-risk endometrial cancer.
Results from a retrospective cohort study found that molecular classification can predict prognosis and relapse patterns among patients with low or intermediate-risk endometrial cancer.
Results from a retrospective...
02/13/2024
Oncology
News
Patient-Reported Quality of Life in Patients With Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab
01/17/2024

By Emry Lloyd

By Emry Lloyd
Researchers have found that a combination therapy of lenvatinib and pembrolizumab can have a statistically significant effect on health-related quality of life scores for patients with endometrial cancer.
Researchers have found that a combination therapy of lenvatinib and pembrolizumab can have a statistically significant effect on health-related quality of life scores for patients with endometrial cancer.
Researchers have found that a...
01/17/2024
Journal of Clinical Pathways

Advertisement

News
Survival Benefits of Carboplatin Plus Paclitaxel and Immunotherapy in Patients With Advanced Endometrial Cancer
11/29/2023

Grace Taylor

Grace Taylor
Shannon Westin, MD, and colleagues analyze the results from the phase 3 DUO-E trial, which examined the effectiveness of immunotherapy + carboplatin/paclitaxel on progression-free survival for patients with endometrial cancer.
Shannon Westin, MD, and colleagues analyze the results from the phase 3 DUO-E trial, which examined the effectiveness of immunotherapy + carboplatin/paclitaxel on progression-free survival for patients with endometrial cancer.
Shannon Westin, MD, and...
11/29/2023
Journal of Clinical Pathways
News
FDA Approves Dostarlimab-gxly With Chemotherapy for Patients With Endometrial Cancer
08/16/2023

Emry Lloyd

Emry Lloyd
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved...
08/16/2023
Journal of Clinical Pathways
News
The Medicaid Expansion’s Impact on Affordable Care: Did it Increase the Number of Patients Receiving Adjuvant Radiation Treatment?
08/02/2023

Emry Lloyd

Emry Lloyd
Researchers conducted a study on the number of patients with endometrial cancer who received adjuvant radiation treatment in the states that implemented further Medicaid expansion.
Researchers conducted a study on the number of patients with endometrial cancer who received adjuvant radiation treatment in the states that implemented further Medicaid expansion.
Researchers conducted a study on...
08/02/2023
Journal of Clinical Pathways

Advertisement

News
Study Analyzes Adjuvant Chemoradiotherapy vs Adjuvant Chemotherapy for Patients with Stage III Endometrial Cancer Following Radical Surgery
04/19/2023

Grace Taylor

Grace Taylor
Si-yu Cao, MD, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Sichuan, China, and colleagues recently compared the effectiveness of adjuvant chemoradiotherapy (ACR) to adjuvant chemotherapy (AC) for...
Si-yu Cao, MD, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Sichuan, China, and colleagues recently compared the effectiveness of adjuvant chemoradiotherapy (ACR) to adjuvant chemotherapy (AC) for...
Si-yu Cao, MD, Department of...
04/19/2023
Journal of Clinical Pathways
News
Beyond Immunotherapy Treatment for Patients With Recurrent Metastatic Endometrial Cancer
04/14/2023
At the 2023 ESMO Gynecological Cancers Congress in Barcelona, Spain, Mansoor Raza Mirza, MD, a clinical oncologist from Rigshospitalet in Denmark, presented data on nonimmunological achievements and the role of HER2, B53, and other molecular...
At the 2023 ESMO Gynecological Cancers Congress in Barcelona, Spain, Mansoor Raza Mirza, MD, a clinical oncologist from Rigshospitalet in Denmark, presented data on nonimmunological achievements and the role of HER2, B53, and other molecular...
At the 2023 ESMO Gynecological...
04/14/2023
Journal of Clinical Pathways
News
The Effectiveness of a Ferroptosis-Related lncRNA Model Based on CFAP58-DT for Predicting Prognosis in Endometrial Cancer
03/17/2023

Grace Taylor

Grace Taylor
Aijun Qin, MD, and colleagues recently investigated the use of a prognostic ferroptosis-related long noncoding RNA (lncRNA) model based on the RNA gene CFAP58-DT for predicting the survival time of patients with endometrial cancer and to help...
Aijun Qin, MD, and colleagues recently investigated the use of a prognostic ferroptosis-related long noncoding RNA (lncRNA) model based on the RNA gene CFAP58-DT for predicting the survival time of patients with endometrial cancer and to help...
Aijun Qin, MD, and colleagues...
03/17/2023
Journal of Clinical Pathways

Advertisement

News
Costs Among Patients With Endometrial Cancer Receiving Postoperative Hemoglobin Level Testing Following Robotic-assisted Hysterectomy
05/18/2022

Ellen Kurek

Ellen Kurek
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study...
05/18/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use